PALM BEACH, Florida, March 8, 2018 /PRNewswire/ --MarketNewsUpdates.com News Commentary
With Canada'slegalization of cannabis set for this summer, new market opportunities are already emerging. Vendors have recently begun selling ice teas, shakes, and juices infused with cannabidiol (CBD). This unique CBD beverage market could be the biggest beneficiary
So far, investors have mostly focused on the psychoactive effects of cannabis, but full legalization means this will also create an opportunity for CBD infused-products to enter the healthy lifestyle niche. This market is worth $5.6 billion in Canada alone based on data from Consumer Health Products Canada.
CBD, which occurs in both families of cannabis plants (hemp and marijuana), is said to bring a variety of health benefits to the human body, according to publications by MedicalNewsToday and Healthline and dozens of clinical studies and research. An article by the Huffington Post last year also confirmed CBD could inhibit the growth of many cancers and tumors, and it's already being used by people suffering from pain and inflammation associated with various diseases. ProjectCBD estimates that CBD may become an effective treatment option for over 50 medical conditions, and could grow into a $2.1 billion consumer market by as early as 2020 - that's a 700% increase from 2016.
Realizing the healing power of CBD, cannabis companies have begun to focus on CBD-infused products. Leading the way is Phivida Holdings Inc. (CSE:VIDA) (OTC:PHVAF), which is making natural health products from premium extracts, foods, and beverages infused with CBD from hemp oil. Hemp is considered superior to marijuana because of its higher CBD content and lower concentration of THC, which is the psychoactive ingredient in cannabis. Phivida Holdings received a head-start on this emerging market by beginning mass CBD consumables production into the newly legalized California market.
Evidence of CBD Effectiveness
In the scientific community, CBD advocacy is on the rise, and evidence of its effectiveness in various health issues is growing. In 2014, a CNN documentary featuring Dr. Sanjay Gupta first reported on the antiepileptic properties of the cannabis ingredient. This was supplemented by the World Health Organization's statement last year that "CBD has been demonstrated as an effective treatment of epilepsy in several clinical trials."
Last year, Forbes covered a story on a medical survey which saw half of the 2,400 respondents - all part of an online community of cannabis patients with mental health issues - claim to have stopped taking traditional medicines following CBD usage.
Phivida Holdings founder John Belfontaine shared his own story about a life-altering experience which inspired his current business. "I was in car accident in 2011 and suffered severe neck and back injuries and a tremendous amount of pain. Doctors insisted on prescription opiates, but I preferred to look for a natural plant-based medicine," Belfontaine said. "I'd heard about medical marijuana and its effects on pain, but the psychoactive side effects of THC just weren't right for me. I was thrilled when I discovered that CBD was found in the highest concentrations in medicinal hemp. When I tried CBD hemp oil for myself, I was amazed at the pain relief and increased mobility. It was a godsend."
Phivida Holdings also recently added former President Red Bull Canada, Jim Bailey as CEO and former Red Bull executive, Michael Cornwell as their new CMO last month to its management team to replicate success they had at Red Bull. . Earlier this year, the company launched its flagship Nano-CBD-infused product in the U.S. for professional athletes and are now actively pursuing partnership opportunities with Canadian LP's to bring their line of functional foods and beverages to Canadians.
CBD Now Recognized Globally
Nations all over the world are noticing the health benefits of CBD. It is projected that the global CBD oil market will grow at a striking 39% annually between 2017 and 2021. Many companies are already planning their global strategies. Phivida Holdings just recently secured a distribution deal in Japan - a key emerging cannabis market, making them a possible contender as a global supplier.
The distribution agreement signed with Asayake Inc. makes Phivida Holdings Inc. (CSE:VIDA) (OTC:PHVAF) an early first mover into Japan, which is the world's third-largest consumer economy. Japan has a health-conscious population and stringent government regulations for products like CBD, where sales of supplements alone are valued at US$10 billion annually.
Aphria Inc. (TSX:APH) (OTCQB:APHQF)
Aphria is one of Canada's lowest-cost medical cannabis producers. The company sells its products through both retail and wholesale channels. It's also engaged in the research and development and commercial production of cannabis oil. In October, Aphria made its first shipment of cannabis oil to Medlab Clinical Ltd., an Australian medical life science company.
Canopy Growth Corp. (TSX:WEED) (OTC:TWMJF)
Canopy Growth is a diversified cannabis and hemp company that offers distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms with operations across four continents. The company was one of the early advocates of hemp production, having acquired various hemp companies early on. In January, Canopy Growth expanded its hemp business into Saskatchewan through its acquisition of Green Hemp Industrie Ltd.
Cronos Group Inc. (TSX-V:CRON)
Cronos Group is a diversified and vertically integrated cannabis company with a presence across four continents. It currently owns Peace Naturals, a licensed producer under Health Canada's Cannabis for Medical Purposes Regulations (ACMPR) that sells medical marijuana and cultivates cannabis oil. Recently, Cronos Group became the first cannabis company to be approved for listing on the Nasdaq stock exchange.
Abcann Global Corp. (TSX-V:ABCN) (OTCQB:ABCCF)
Abcann Global currently holds Health Canada licenses to produce and sell cannabis. The company is also looking to expand its operations in Australia, Germany, and Israel. In January, Abcann received its license to produce medical cannabis oils, with sales approval expected
CBD Beverages Could Be A Cornerstone of Canadian Economy
With legalization of CBD-infused foods and beverages set to become official this year, the industry is set to challenge energy drinks and perhaps even alcohol in the legal recreational product market.
Being the first pure-play U.S. focused CBD hemp company from Canada, Phivida Holdings Inc. (CSE:VIDA) (OTC:PHVAF) has the opportunity to potentially dominate both markets.Since its IPO in December, the company saw its share price nearly double in three months, starting at $0.78 to what is now a $1.49 stock.
People's perception of cannabis consumption have changed. Cannabis is no longer something just to get "high" on. As cannabis legalization begins to spread around the globe, a unique market based on the health appeals of CBD will likely emerge. Just how big this market could grow is anyone's guess, but the potential is there for it to rival Red Bull and become one of the hottest sectors in the beverage industry.
For a more in-depth look at Phivida Holdings Inc. (CSE:VIDA)(OTC:PHVAF), check out the full report here.
DISCLAIMER: FinancialPost.com (FP) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with FP or any company mentioned herein. The commentary, views and opinions expressed in this release by FP are solely those of FP and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable FP and FNM for any investment decisions by their readers or subscribers. FP and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author (FP), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (FP) has not independently verified or otherwise investigated all such information. None of the Author, FP, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated forty five hundred dollars by FP, a non-affiliated third party to distribute this release on behalf of Phivida Holdings Inc.
FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FP and FNM undertake no obligation to update such statements.
Media Contact: FN Media Group, LLC firstname.lastname@example.org +1(561)325-8757
Subscribe to our Free Newsletters!
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...
Unintended pregnancies are very common these days, and so one in about four pregnant women go for ...View All